Short answer · Medically reviewed summary · Last updated: 2026-04-07
Polycystic Ovary Syndrome (PCOS) is considered a common endocrine condition, estimated to affect between 5% and 15% of reproductive-aged individuals assigned female at birth globally. Prevalence and Classification While often discussed in the context of complex health, Polycystic Ovary Syndrome is not classified as a rare disease; rather, it is one of the most common reproductive and endocrine disorders. Because the diagnostic criteria—such as the Rotterdam criteria—can vary, estimates of prevalence fluctuate significantly depending on the population studied and the clinical tools used.
2 people with Polycystic Ovary Syndrome have shared their first-person experience on this question at DiseaseMaps.
What is the prevalence of Polycystic Ovary Syndrome?
Prevalence of Polycystic Ovary Syndrome: how many people are affected worldwide, differences by sex and region, with sources.
Polycystic Ovary Syndrome (PCOS) is considered a common endocrine condition, estimated to affect between 5% and 15% of reproductive-aged individuals assigned female at birth globally.
Prevalence and Classification
While often discussed in the context of complex health, Polycystic Ovary Syndrome is not classified as a rare disease; rather, it is one of the most common reproductive and endocrine disorders. Because the diagnostic criteria—such as the Rotterdam criteria—can vary, estimates of prevalence fluctuate significantly depending on the population studied and the clinical tools used. True prevalence is likely higher than official clinical estimates due to widespread underdiagnosis and misdiagnosis in primary care settings.
Demographics and Onset
Polycystic Ovary Syndrome exclusively affects individuals with ovaries. While symptoms, such as irregular periods or acne, often manifest during adolescence, many individuals are not formally diagnosed until they experience trouble conceiving in adulthood. Epidemiological studies suggest that Polycystic Ovary Syndrome prevalence varies by ethnicity, with higher rates often reported in South Asian and Middle Eastern populations compared to Caucasian cohorts, though these differences may be influenced by environmental factors and diagnostic access.
Challenges in Data and Community Perspective
Accurate incidence data—the number of new cases per year—is difficult to establish because the condition is chronic and symptoms often develop insidiously over time. Many patients navigate years of symptoms before receiving a formal diagnosis. At DiseaseMaps.org, we have seen 1,381 people with Polycystic Ovary Syndrome join our community to share their lived experiences. This data serves as a vital, real-world complement to medical literature, highlighting the significant burden of anxiety, depression, and reproductive challenges that clinical metrics often fail to capture fully.
Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.
References
- NIH Genetic and Rare Diseases Information Center (GARD)
- Orphanet: The portal for rare diseases and orphan drugs
- World Health Organization (WHO) Fact Sheets on Reproductive Health
References:
Trivax, B., & Azziz, R. (2007). Diagnosis of polycystic ovary syndrome. Clinical Obstetrics and Gynecology, 50, 168–177. [top]
NICHD, NIH, DHHS. (2008). Beyond infertility: Polycystic ovary syndrome (PCOS) (08-5863). Washington, DC: U.S. Government Printing Office.[top]
Posted May 22, 2017 by RKaye09 5080
Posted Jun 21, 2018 by Shelby 2770
